NCT05725291 - AMT-116 in Patients With Advanced Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Advanced Solid Tumor

Interventions

DRUG

AMT-116

Administered intravenously

Trial Locations (10)

RECRUITING

Macquarie University Hospital, Sydney

RECRUITING

Alfred Hospital, Victoria Park

RECRUITING

Austin Health, Victoria Park

RECRUITING

Cabrini Hospital, Victoria Park

RECRUITING

Southern Oncology Clinical Research Unit, Adelaide

RECRUITING

Carolina BioOncology Institute, LLC, Cary

RECRUITING

Mary Crowley Cancer Research Centers, Dallas

NOT_YET_RECRUITING

Sarah Cannon Research Institute, Denver

NOT_YET_RECRUITING

University of California San Francisco Cancer Center, San Francisco

RECRUITING

ICON Cancer Centre, Brisbane